Skip to main content
Clinical Trials/NCT02875106
NCT02875106CompletedNot Applicable

BAYathlon - a Digital Non-interventional AF Screening Study to Identify Commercial Pulse Detection Systems (CPDS) Detecting AF and Sinus Rhythm Parallel to ECG Recording Within Routine Clinical Setting

Bayer1 site in 1 country165 target enrollmentStarted: November 8, 2017Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Bayer
Enrollment
165
Locations
1
Primary Endpoint
The rate of correctly detected atrial fibrillation signals by CPDS in reference to ECG (sensitivity of CPDS).

Study Overview

Brief Summary

The primary objective in this study is to identify commercial pulse detection systems (CPDS) parallel to electrocardiogram (ECG) recording within routine clinical setting, which are able to detect atrial fibrillation or sinus rhythm of screened patients.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adult female and male patients for whom the decision to record an ECG was made as per investigator's routine treatment practice
  • Patient able and willing to provide signed informed consent

Exclusion Criteria

  • Patients with any comorbidities or abnormalities of heart function or rhythm, which might, in the opinion of the investigator, interfere with the evaluation of study data
  • Patients participating in an investigational program with interventions outside of routine clinical practice

Outcomes

Primary Outcomes

The rate of correctly detected atrial fibrillation signals by CPDS in reference to ECG (sensitivity of CPDS).

Time Frame: 120 seconds

This will be calculated as proportion of patients with atrial fibrillation diagnosed by CPDS record out of the total number of patients diagnosed with atrial fibrillation by ECG record (for patients with diagnosis for both recordings available).

Secondary Outcomes

  • The rate of correctly detected atrial fibrillation signals by CPDS in reference to ECG (sensitivity of CPDS).(60 seconds, 180 seconds, 240 seconds, 300 seconds)
  • The rate of correctly detected AF of the applied algorithm of the ECG-data in reference to the primary diagnosis of the investigator using the ECG-graph (sensitivity of algorithm).(120 seconds)
  • The rate of correctly detected sinus rhythm signals by CPDS in reference to ECG (sensitivity of CPDS).(120 seconds)

Investigators

Sponsor
Bayer
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials